Massachusetts General Hospital in the next few weeks will launch a large, long-awaited test of whether a controversial cutting-edge proton beam therapy is more effective than standard radiation treatment for prostate cancer. Jason Efstathiou, HMS assistant professor of radiation oncology at Massachusetts General Hospital and Karen Marcus, HMS associate professor of radiation oncology at Children’s Hospital Boston, are quoted.

Read full article